India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
This article was originally published in The Pink Sheet Daily
Executive Summary
Disseminated power appears to be the goal, but would the system require four times the paperwork?
You may also be interested in...
India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority
MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions
Parliamentary Panel Not Yet Ready To Recommend India’s CDA Bill
NEW DELHI - A parliamentary committee examining the bills to set up a central drug authority in India is not yet set to give its recommendations, which would pave the way for the bills to be debated and passed in the parliament. The CDA bill has been approved by the country's Cabinet of Ministers and is currently with the parliamentary panel
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.